{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T03:07:43Z","timestamp":1769828863630,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.neulet.2011.07.020","type":"journal-article","created":{"date-parts":[[2011,7,24]],"date-time":"2011-07-24T15:37:35Z","timestamp":1311521855000},"page":"37-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Decreased serum brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia"],"prefix":"10.1016","volume":"502","author":[{"given":"Yan Qiu","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya Qin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei Hong","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu","family":"De Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cunbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Kosten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2011.07.020_bib0005","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/39885","article-title":"Anterograde transport of brain-derived neurotrophic factor and its role in the brain","volume":"389","author":"Altar","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2011.07.020_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2006.12.026","article-title":"Brain derived neurotropic factor in first-episode psychosis","volume":"91","author":"Buckley","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neulet.2011.07.020_bib0015","doi-asserted-by":"crossref","unstructured":"C.C. Chen, T.L. Huang, Effects of antipsychotics on the serum BDNF levels in schizophrenia. Psychiatry Res. (February) (2011) (Epub ahead of print).","DOI":"10.1016\/j.psychres.2011.01.011"},{"key":"10.1016\/j.neulet.2011.07.020_bib0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0006-8993(94)91857-0","article-title":"NT-3 and BDNF protect CNS neurons against metabolic\/excitotoxic insults","volume":"640","author":"Cheng","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2011.07.020_bib0025","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/YCO.0b013e3282f53132","article-title":"Tardive dyskinesia and new antipsychotics","volume":"21","author":"Correll","year":"2008","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.neulet.2011.07.020_bib0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neulet.2007.04.001","article-title":"Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder","volume":"420","author":"Gama","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2011.07.020_bib0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.eurpsy.2009.10.001","article-title":"Comparison of brain N-acetylaspartate levels and serum brain-derived neurotrophic factor (BDNF) levels between patients with first-episode schizophrenia psychosis and healthy controls","volume":"26","author":"Goto","year":"2011","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.neulet.2011.07.020_bib0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jpsychires.2006.01.005","article-title":"Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics","volume":"41","author":"Grillo","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neulet.2011.07.020_bib0045","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35075076","article-title":"BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization","volume":"411","author":"Guillin","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2011.07.020_bib0050","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jpsychires.2005.11.004","article-title":"Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients","volume":"40","author":"Huang","year":"2006","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neulet.2011.07.020_bib0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.schres.2008.01.017","article-title":"Low serum levels of brain derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia","volume":"101","author":"Ikeda","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neulet.2011.07.020_bib0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.schres.2009.12.035","article-title":"Decreased BDNF in patients with antipsychotic na\u00efve first episode schizophrenia","volume":"19","author":"Jindal","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neulet.2011.07.020_bib0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neulet.2004.08.045","article-title":"Brain-derived neurotrophic factor serum concentrations are increased in drug naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse","volume":"71","author":"Jockers-Scher\u00fcbl","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2011.07.020_bib0070","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.pnpbp.2008.05.016","article-title":"No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients","volume":"32","author":"Kang","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2011.07.020_bib0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0304-3940(02)00529-3","article-title":"Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets","volume":"328","author":"Karege","year":"2002","journal-title":"Neurosci. Lett."},{"issue":"Suppl. 7","key":"10.1016\/j.neulet.2011.07.020_bib0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1192\/S0007125000291514","article-title":"Negative syndrome scale (PANSS): rationale and standardization","volume":"155","author":"Kay","year":"1989","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neulet.2011.07.020_bib0085","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.pnpbp.2010.05.013","article-title":"Effects of olanzapine on brain-derived neurotrophic factor gene promoter activity in SH-SY5Y neuroblastoma cells","volume":"34","author":"Lee","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2011.07.020_bib0090","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.ne.19.030196.001445","article-title":"Physiology of the neurotrophins","volume":"19","author":"Lewin","year":"1996","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neulet.2011.07.020_bib0095","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1192\/bjp.163.6.776","article-title":"Negative symptoms as a risk factor for tardive dyskinesia in schizophrenia","volume":"163","author":"Liddle","year":"1993","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neulet.2011.07.020_bib0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00023210-200317010-00004","article-title":"Oxidative mechanisms and tardive dyskinesia","volume":"17","author":"Lohr","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neulet.2011.07.020_bib0105","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0306-4522(03)00099-X","article-title":"Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine","volume":"119","author":"Narita","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2011.07.020_bib0110","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1097\/00001756-199808240-00030","article-title":"Medial nigral dopamine neurons have rich neurotrophin support in humans","volume":"9","author":"Nishio","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.neulet.2011.07.020_bib0115","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.schres.2006.05.028","article-title":"Decresed levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients","volume":"6","author":"Palomino","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neulet.2011.07.020_bib0120","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0028-3908(98)00141-5","article-title":"Transport of brain-derived neurotrophic factor across the blood\u2013brain barrier","volume":"7","author":"Pan","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2011.07.020_bib0125","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jpsychires.2008.05.010","article-title":"Differential effects of ziprasidone and haloperidol on immobilization stress-induced mRNA BDNF expression in the hippocampus and neocortex of rats","volume":"3","author":"Park","year":"2009","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neulet.2011.07.020_bib0130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1440-1819.2009.01976.x","article-title":"Genetic association of BDNF val66met and GSK-3beta-50T\/C polymorphisms with tardive dyskinesia","volume":"63","author":"Park","year":"2009","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neulet.2011.07.020_bib0135","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neulet.2011.01.039","article-title":"Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia, a positive correlation","volume":"491","author":"Pedrini","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2011.07.020_bib0140","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1017\/S1461145709991015","article-title":"Decresed BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology","volume":"3","author":"Pillai","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neulet.2011.07.020_bib0145","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.pnpbp.2004.05.008","article-title":"Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment","volume":"28","author":"Pirildar","year":"2004","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2011.07.020_bib0150","unstructured":"Psychopharmacology Research Branch, National Institute of Mental Health, Abnormal involuntary movement scale (AIMS), in: W. Gay (Ed.), ECDEU Assessment Manual for Psychopharmacology, Revised, US Dept Health, Education, and Welfare publication (ADM) 76-338, National Institute of Mental Health, Rockville, MD, 1976, pp. 534\u2013537."},{"key":"10.1016\/j.neulet.2011.07.020_bib0155","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0006-8993(95)01321-0","article-title":"Presence of brain derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay","volume":"709","author":"Radka","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2011.07.020_bib0160","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neulet.2008.05.022","article-title":"Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia","volume":"439","author":"Reis","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2011.07.020_bib0165","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.pnpbp.2008.04.007","article-title":"Investigation of serum BDNF levels in drug-naive patients with schizophrenia","volume":"32","author":"Rizos","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2011.07.020_bib0170","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/15622970802182733","article-title":"Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics","volume":"1","author":"Rizos","year":"2010","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2011.07.020_bib0175","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archpsyc.1982.04290040080014","article-title":"Research diagnoses for tardive dyskinesia","volume":"39","author":"Schooler","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neulet.2011.07.020_bib0180","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2003.08.004","article-title":"Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls","volume":"51","author":"Shimizu","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2011.07.020_bib0185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.schres.2004.08.004","article-title":"Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements","volume":"74","author":"Tan","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neulet.2011.07.020_bib0190","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0165-1781(02)00127-0","article-title":"Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients","volume":"110","author":"Toyooka","year":"2002","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neulet.2011.07.020_bib0195","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.pnpbp.2007.03.010","article-title":"Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients","volume":"31","author":"Yoshimura","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2011.07.020_bib0200","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3109\/15622970802309617","article-title":"Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients","volume":"11","author":"Yoshimura","year":"2010","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2011.07.020_bib0205","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.euroneuro.2009.01.001","article-title":"Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia","volume":"19","author":"Zai","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neulet.2011.07.020_bib0210","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jpsychires.2006.08.007","article-title":"Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics","volume":"1","author":"Zhang","year":"2007","journal-title":"J. Psychiatr. Res."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394011010688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394011010688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:13:05Z","timestamp":1759608785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394011010688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0304394011010688"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2011.07.020","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased serum brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2011.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}